Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Funko Inc (FNKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Funko Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Funko Inc trades at $6.49 (market cap $353.05M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 13.3× Funko Inc's market cap, and Funko Inc is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Funko Inc for 33 Days on average.
| DFTX | FNKO | |
|---|---|---|
Market Cap | $4.71B | $353.05M |
Volume | 1,966,636 | 915,655 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $7.10 |
52-Week Low | $10.68 | $2.81 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $3.67B | $573.70M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FNKO trades at $6.50, up 6.38% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with Q2 2026 earnings beating expectations, revenue growth of 7% to $207.7M, and raised EBITDA guidance to $105M. Despite negative net margins, the stock trades at attractive valuations with P/S of 0.37 and EV/EBITDA of 6.7x. Recent management changes and product expansions signal strategic repositioning.
FNKO presents a turnaround opportunity with improving operational metrics and analyst consensus target of $7.58 (17% upside). Key risks include persistent negative profitability, high debt levels, and consumer discretionary sensitivity. The bullish technical setup combined with fundamental improvements supports cautious optimism for value investors seeking exposure to pop culture branding.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →
